has been cited by the following article(s):
|
[1]
|
The Pharmacology of Curaderm in the Treatment of Basal Cell Carcinoma
|
|
Clin Med Rev Case Rep,
2022 |
|
|
|
|
[2]
|
Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival
|
|
2020 |
|
|
|
|
[3]
|
Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma
|
|
2020 |
|
|
|
|
[4]
|
First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm: A Case Report
|
|
2020 |
|
|
|
|
[5]
|
Outside the Box Cancer Therapies: Alternative Therapies That Treat and Prevent Cancer
|
|
2019 |
|
|
|
|
[6]
|
“Dr. Stengler and Dr. Anderson expertly provide clear, practical tools that can possibly save your life or someone close to you. By harnessing the healing power …
|
|
2018 |
|
|
|
|
[7]
|
Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
|
|
2017 |
|
|
|
|
[8]
|
A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity. Relevance to BEC and Solamargine, Example of a …
|
|
2015 |
|
|
|
|
[9]
|
A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical …
|
|
2015 |
|
|
|
|
[10]
|
Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases
|
|
Medicinal research reviews,
2015 |
|
|
|
|
[11]
|
A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation Curaderm BEC5
|
|
Journal of Cancer Treatment and Research,
2015 |
|
|
|
|
[12]
|
Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides
|
|
International Journal of Clinical Medicine,
2015 |
|
|
|
|
[13]
|
Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
|
|
Journal of Cancer Therapy,
2015 |
|
|
|
|
[14]
|
Topical Cream Curadermbec5 Treats a Recalcitrant Basal Cell Carcinoma
|
|
2015 |
|
|
|
|
[15]
|
AGROBACTERIUM RHIZOGENES-MEDIATED HAIRY ROOT OF APPLE OF SODOM (SOLANUM MAMMOSUM L.) FOR OPTIMIZED PRODUCTION OF …
|
|
2015 |
|
|
|
|
[16]
|
A standardized plant extract containing a target compound is acceptable as a potent therapeutic entity: Relevance to BEC and solamargine, a topical clinical …
|
|
2015 |
|
|
|
|
[17]
|
A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis
|
|
British Journal of Medicine and Medical Research,
2014 |
|
|
|
|
[18]
|
A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis.
|
|
British Journal of Medicine and Medical Research,
2014 |
|
|
|
|
[1]
|
Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
International Journal of Clinical Medicine,
2017
DOI:10.4236/ijcm.2017.812064
|
|
|
|
|
[2]
|
Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases
Medicinal Research Reviews,
2016
DOI:10.1002/med.21346
|
|
|
|
|
[3]
|
Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides
International Journal of Clinical Medicine,
2015
DOI:10.4236/ijcm.2015.65042
|
|
|
|
|
[4]
|
Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.612114
|
|
|
|